Ryan Haumschild, PharmD, MS, MBA, CPEL, explains the impact recently FDA-approved gepotidacin will have on uncomplicated UTIs and what this means in terms of antibiotic stewardship.
Ryan Haumschild, PharmD, MS, MBA, CPEL
Advertisement
Ryan Haumschild, PharmD, MS, MBA, CPEL, is vice president of pharmacy at Emory Healthcare and Winship Cancer Institute.
Articles by Ryan Haumschild, PharmD, MS, MBA, CPEL
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Birth defect risk not impacted by COVID-19 vaccination
2
Breakthrough endometriosis test detects biomarker in menstrual blood
3
Eve Zaritsky, MD, highlights improved oral contraceptive access from e-visits
4
Contemporary OB/GYN week in review: birth complications, fasting, and more
5
